Unknown

Dataset Information

0

Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor.


ABSTRACT: Genetically modified T cells to recognize tumor-associated antigens by transgenic TCRs or chimeric antigen receptors (CAR) have been successfully applied in clinical trials. However, the disadvantages of either TCR mismatching or the requirement of a surface tumor antigen limit their wider applications in adoptive T cell therapy. A TCR-like chimeric receptor, specific for the melanoma-related gp100/HLA-A2 complex was created by joining a TCR-like antibody GPA7 with the endodomains of CD28 and CD3-ζ chain. This TCR-like CAR, GPA7-28z, was subsequently introduced into human T cells. Retargeted T cells expressing GPA7-28z could exhibit efficient cytotoxic activities against human melanoma cells in vitro in the context with HLA-A2. Furthermore, infusion of GPA7-28z-transduced T cells suppressed melanoma progression in a xenograft mouse model. Redirecting human T cells with TCR-like CARs would be a promising alternative approach to TCR-mediated therapy for melanoma patients, which is also feasible for targeting a variety of other tumor antigens.

SUBMITTER: Zhang G 

PROVIDER: S-EPMC3880964 | biostudies-other | 2014

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC6796553 | biostudies-literature
| S-EPMC5587706 | biostudies-literature
| S-EPMC3822734 | biostudies-literature
| S-EPMC3672777 | biostudies-literature
| S-EPMC9344815 | biostudies-literature
| S-EPMC5991104 | biostudies-literature
| S-EPMC5132227 | biostudies-literature
| S-EPMC9564159 | biostudies-literature
| S-EPMC4705591 | biostudies-literature
| S-EPMC5669573 | biostudies-literature